FoRT
Trial overview
A Phase III multi-centre randomised controlled trial of low dose radiotherapy for follicular lymphoma.
Inclusion criteria
i. Patients aged over 18 with no upper age limit
ii. Histologically proven follicular non-Hodgkin’s lymphoma
iii. Biopsy material available for histological review
iv. Radiation indicated for definitive treatment of stage IA or IIA disease or for palliation by virtue of tumour bulk or anatomical position.
v. Written informed consent
Exclusion criteria
i. Histological sub-types other than follicular non-Hodgkin’s lymphoma
ii. Predicted prognosis less than three months
iii. Chemotherapy within four weeks of planned radiotherapy
Contact details
Other trials currently active for Follicular Lymphoma
Short CHemoRadioImmunotherapy in Follicular Lymphoma Trial of 90Y Ibritumomab tiuxetan (ZevalinTM) as therapy for first and second relapse in Follicular Lymphoma - a Prospective Phase II study